Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease

This study has been completed.
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Nicholas Shaheen, University of North Carolina, Chapel Hill Identifier:
First received: October 2, 2009
Last updated: January 6, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)